CN102430096A - Medicament for treating rheumatic or rheumatoid diseases - Google Patents
Medicament for treating rheumatic or rheumatoid diseases Download PDFInfo
- Publication number
- CN102430096A CN102430096A CN2011103997032A CN201110399703A CN102430096A CN 102430096 A CN102430096 A CN 102430096A CN 2011103997032 A CN2011103997032 A CN 2011103997032A CN 201110399703 A CN201110399703 A CN 201110399703A CN 102430096 A CN102430096 A CN 102430096A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicament
- rheumatoid diseases
- rheumatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating rheumatic or rheumatoid diseases, which is prepared from the following crude drugs in part by weight: 50 parts of notopterygium root, 50 parts of radix angelicae pubescentis, 50 parts of radices sileris, 50 parts of processed Radix Aconiti, 40 parts of zaocys dhumnade, 60 parts of cortex acanthopanacis, 60 parts of radix angelicae, 40 parts of red flower, 50 parts of radix curcumae, 50 parts of rhizoma sparganii, 50 parts of Ligusticum wallichii, 60 parts of radix achyranthis bidentatae, 40 parts of frankincense, 40 parts of myrrh, 40 parts of borneol, 50 parts of Angelica sinensis, 30 parts of lumbricus, 60 parts of Astragalus mongholicus, 60 parts of ligusticum sinense oliver and 40 parts of ephedra. The medicament for treating the rheumatic or rheumatoid diseases has the effects of promoting blood circulation and removing blood stasis, eliminating swelling and stopping pains, removing dampness and clearing away cold, smoothing main and collateral channels as well as removing toxin and relieving itching, and is capable of effectively treating the rheumatic or rheumatoid diseases.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of treatment rheumatism or rheumatoid medicament.
Background technology
Rheumatism and rheumatoid disease are meant with muscle, arthralgia to be one type of disease of master.The main connective tissue that influences health.The traditional Chinese medical science is thought: imbalance of YIN and YANG, All kinds of diseases and ailments break out.Belong to one type of arthromyodynia, refer to wind and the wet two kinds of pathogenic factor disease due to combining.The cause of disease of disadvantage is a lot, but nothing more than exopathogenic factor and endogenous cause of ill.Brilliantly point out in " element is asked the numbness opinion ": " wet three gas of wind and cold are assorted extremely, close and are numbness ... ".Disease sees that headache, heating, slight perspiration, aversion to wind, heavy sensation of the body, dysuria, joint are ached, can not be bent and stretched etc.Never stop for the new treatment rheumatism or the searching of rheumatoid medicine.
Summary of the invention
The purpose of this invention is to provide a kind of treatment rheumatism or rheumatoid medicament.
In order to realize the object of the invention; The present invention provides a kind of treatment rheumatism or rheumatoid medicament, and it is to be processed by weight by following bulk drugs: Rhizoma Et Radix Notopterygii 50, Radix Angelicae Pubescentis 50, windproof 50, Radix Aconiti Preparata 50, Zaocys 40, Cortex Acanthopancis 60, the Radix Angelicae Dahuricae 60, Flos Carthami 40, Radix Curcumae 50, triangular 50, Rhizoma Chuanxiong 50, Radix Achyranthis Bidentatae 60, Olibanum 40, Myrrha 40, Borneolum Syntheticum 40, Radix Angelicae Sinensis 50, Pheretima 30, the Radix Astragali 60, Rhizoma Ligustici 60 and Herba Ephedrae 40.
Preferably, said medicament is tablet, unguentum, capsule or hard capsule.
Medicament blood circulation promoting and blood stasis dispelling of the present invention, detumescence relieve the pain, dehumidify cold expelling, the meridian dredging, detoxifying and relieving itching can be treated rheumatism or rheumatoid disease effectively.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 tablet of the present invention
Get Rhizoma Et Radix Notopterygii 50 grams, Radix Angelicae Pubescentis 50 grams, windproof 50 grams, Radix Aconiti Preparata 50 grams, Zaocys 40 grams, Cortex Acanthopancis 60 grams, the Radix Angelicae Dahuricae 60 grams, Flos Carthami 40 grams, Radix Curcumae 50 grams, triangular 50 grams, Rhizoma Chuanxiong 50 grams, Radix Achyranthis Bidentatae 60 grams, Olibanum 40 grams, Myrrha 40 grams, Borneolum Syntheticum 40 grams, Radix Angelicae Sinensis 50 grams, Pheretima 30 grams, the Radix Astragali 60 grams, Rhizoma Ligustici 60 grams and Herba Ephedrae 40 grams, cross 80 mesh sieves.Take by weighing Icing Sugar 500 grams then, cross 80 mesh sieves and above-mentioned raw materials medicine and mix.HPMC aqueous solution with 3 weight % is made binding agent system soft material, and granulate (granulating two times) with 16 order nylon mesh, drying is 2 hours under 60 ℃, with 16 purpose nylon mesh granulate.Add the magnesium stearate of the carboxymethyl starch sodium and 10 grams of 400 grams again, mixing is with 1000 of the drift tablettings of diameter 14mm.
Experimental example
Select 60 routine rheumatisants, male 30 examples, women 30 examples, the mean age is 48 years old.Diagnostic criteria: with reference to the standard of " American Rheumatism Association " formulation, that is: according to medical history, physical diagnosis and radiological examination result: knee-joint pain, promptly confirm clinical diagnosises for 3 that possess simultaneously in following 6 conditions, 1. radiology shows hyperosteogeny formation; 2. rise morning and stiffly be less than 30 minutes; 3. the bone sound is arranged during joint motion; 4. the knee joint bone increases; 5. the bone tenderness is arranged; 6. not having tangible synovial membrane heats up.
Use the tablet that makes among the embodiment 1 to treat, wherein one day 3 times, each 3, treating February is a course of treatment.
Efficacy determination: 1. produce effects: gonalgia transference cure, the stiff time in morning shortens or does not have the deadlock in morning, and physico-chemical examination is normal.1. take a turn for the better: gonalgia sx, physico-chemical examination makes moderate progress.Invalid: the gonalgia does not have and alleviates, and physico-chemical examination does not have change.
Through the observation of a course of treatment is arranged, finding has 60 patient treatment effects to be produce effects, and during whole treatment, does not observe tangible untoward reaction.
After treating a course of treatment, all the patient is followed up a case by regular visits to weekly, continue half a year, find the sign of recurrence.
Claims (2)
1. treat rheumatism or rheumatoid medicament for one kind; It is characterized in that it is to be processed by weight by following bulk drugs: Rhizoma Et Radix Notopterygii 50, Radix Angelicae Pubescentis 50, windproof 50, Radix Aconiti Preparata 50, Zaocys 40, Cortex Acanthopancis 60, the Radix Angelicae Dahuricae 60, Flos Carthami 40, Radix Curcumae 50, triangular 50, Rhizoma Chuanxiong 50, Radix Achyranthis Bidentatae 60, Olibanum 40, Myrrha 40, Borneolum Syntheticum 40, Radix Angelicae Sinensis 50, Pheretima 30, the Radix Astragali 60, Rhizoma Ligustici 60 and Herba Ephedrae 40.
2. treatment rheumatism according to claim 1 or rheumatoid medicament is characterized in that, said medicament is tablet, unguentum, capsule or hard capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103997032A CN102430096B (en) | 2011-12-06 | 2011-12-06 | Medicament for treating rheumatic or rheumatoid diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103997032A CN102430096B (en) | 2011-12-06 | 2011-12-06 | Medicament for treating rheumatic or rheumatoid diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102430096A true CN102430096A (en) | 2012-05-02 |
| CN102430096B CN102430096B (en) | 2013-03-13 |
Family
ID=45978681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103997032A Expired - Fee Related CN102430096B (en) | 2011-12-06 | 2011-12-06 | Medicament for treating rheumatic or rheumatoid diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102430096B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103285273A (en) * | 2013-05-20 | 2013-09-11 | 段恒德 | Medicinal liquor for treating rheumatic arthritis and chronic infectious arthritis |
| CN108686173A (en) * | 2018-08-24 | 2018-10-23 | 上海祁传生物科技有限公司 | A kind of expelling wind and clearing away cold Chinese medicine preparation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1966018A (en) * | 2006-10-25 | 2007-05-23 | 雒宏志 | Chinese medicinal formulation for treating rheumatic and rheumatoid disease |
| CN102188623A (en) * | 2011-04-12 | 2011-09-21 | 郑延明 | Liquid plaster for treating osseous rheumatism and preparation method thereof |
-
2011
- 2011-12-06 CN CN2011103997032A patent/CN102430096B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1966018A (en) * | 2006-10-25 | 2007-05-23 | 雒宏志 | Chinese medicinal formulation for treating rheumatic and rheumatoid disease |
| CN102188623A (en) * | 2011-04-12 | 2011-09-21 | 郑延明 | Liquid plaster for treating osseous rheumatism and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103285273A (en) * | 2013-05-20 | 2013-09-11 | 段恒德 | Medicinal liquor for treating rheumatic arthritis and chronic infectious arthritis |
| CN108686173A (en) * | 2018-08-24 | 2018-10-23 | 上海祁传生物科技有限公司 | A kind of expelling wind and clearing away cold Chinese medicine preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102430096B (en) | 2013-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703692A (en) | Chinese medicinal preparation for treating bone fracture and preparation method thereof | |
| CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN102091295B (en) | Chinese medicinal composition for treating femoral head necrosis and preparation method thereof | |
| CN100376229C (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
| CN101085327A (en) | Traditional Chinese medicine cutaneous permeable agent | |
| CN101167874B (en) | Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid oarthritis | |
| CN102120017B (en) | Chinese medicinal preparation for treating uterus myoma | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN104161868A (en) | Drug for treating rheumatoid arthritis | |
| CN102166277A (en) | Waist healing pill | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN102247501A (en) | Medicine for treating soft tissue injury | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN103239700A (en) | Medicament for treating rheumatism | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN104162088A (en) | Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof | |
| CN103784541A (en) | Traditional Chinese medicine for treating pains on neck, shoulders, waist and legs | |
| CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
| CN103271961B (en) | Preparation for treating rheumatic bone diseases | |
| CN102670740B (en) | Drug composition for treating soft tissue injuries and preparation process thereof | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN100394925C (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN102178758A (en) | Medicament for treating peripheral nerve of diabetes | |
| CN106310084A (en) | Medicine for treating rheumatism and sciatica and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130313 Termination date: 20151206 |
|
| EXPY | Termination of patent right or utility model |